Ph 2 Elacestrant in ER Positive Uterine Sarcomas

Clinical trial NCT07467772 · RECRUITING

Trial details

NCT number: NCT07467772
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Uterine Sarcoma Uterine Leiomyosarcoma Endometrial Stromal Sarcoma ESS Perivascular Epithelioid Cell Tumors Uterine Adenosarcoma Uterine PEComa Estrogen Receptor Positive Tumor uLMS

Start date: 2026-03-25
Primary completion: 2027-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.